# SemperVirens VC

> SemperVirens VC is a venture capital firm backing technology companies in healthcare, financial services, and the workforce. It pairs investment with buyer introductions, sector advice, and distribution partnerships, and runs an accelerator for early-stage founders.

- **Founded:** 2018
- **Headquarters:** San Mateo, United States
- **Founders:** Robby Peters (Co-founder and Managing Partner), Greg Golub (Co-founder and Managing Partner)
- **Products:** Early-stage venture investing, Growth opportunity investing, SemperSystem, SemperVirens Accelerator
- **Notable:** Announced $177 million across two fund closes in March 2025., ADP’s October 2023 announcement reported more than $150 million AUM and 52 portfolio companies., June 2025 launch materials reported approximately $300 million AUM and more than 70 portfolio companies.

## Products & services

- **Early-stage venture investing** — Core investment strategy backing companies in healthcare, workforce technology, and financial services. Core Fund III closed at $141 million in 2025.
- **Growth opportunity investing** — Follow-on and growth investments; Growth Opportunity Fund II closed at $36 million in 2025.
- **SemperSystem** — The firm’s named network and operating approach combining investors, advisors, enterprise buyers, market insights, and distribution partners.
- **SemperVirens Accelerator** — Launched June 2025 for pre-seed through Series A companies, with buyer feedback, distribution advice, and scaling support. The current program describes cohorts of four and an investment component.

## Achievements

- Announced $177 million across two fund closes in March 2025.
- ADP’s October 2023 announcement reported more than $150 million AUM and 52 portfolio companies.
- June 2025 launch materials reported approximately $300 million AUM and more than 70 portfolio companies.
- The current homepage reports 5,500+ customer introductions, 200+ executive advisors, and $200 million+ directly influenced ARR; these are firm-reported measures, not SemperVirens revenue.
- In its May 2026 review of 2025, the firm said it had returned over half of Fund I.

## Latest updates

- **2026-02** — Amanda Paolino published an insurance AI thesis arguing for outcome-based delivery and integration with existing systems.
- **2026-05** — Published its 2025 year-in-review, reporting that it returned over half of Fund I.
- **2026-07** — Published Four Ways to Win in AI-Native Services, emphasizing existing services budgets, workflow ownership, proprietary operational data, and labor shortages.

## Links

- Website: https://www.sempervirensvc.com/
- LinkedIn: https://www.linkedin.com/company/sempervirensvc

---

Profile page: https://yespress.io/sempervirens-vc
Published by YesPress — https://yespress.io
Last updated: 2026-10-25